<DOC>
	<DOCNO>NCT02857400</DOCNO>
	<brief_summary>Prospective , open label , randomize multicentric study evaluate efficacy organize consultation `` return home '' compare current standard care patient hospitalize due metastatic solid tumor cancer . Subject randomize ( 1:1 ) describe : â€¢ Arm A ( standard ) : current standard care ; connection documentation fax GP ( General practitioner ) day patient 's discharge Arm B ( experimental ) : CREDO standard care , organize consultation `` return home '' patient , GP DESC ( diploma complementary specialize study ) patient 's referent GP</brief_summary>
	<brief_title>Evaluation Organized Consultation `` Return Home '' Patients With Metastatic Cancer ( CREDO )</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>1 . Age &gt; 18 year old 2 . Subject hospitalized oncology dedicate center administration first chemotherapy cycle . 3 . Subject metastatic solid tumor whatever organ 4. subject plan discharge home chemotherapy administration 5 . Affiliated French social security system . 6 . Subjects must provide write informed consent prior studyspecific procedure assessment 1 . Subject include another trial therapeutic purpose 2 . Subject close circle applicable unreachable phone 3 . Pregnant breastfeedings woman 4 . Any serious and/or unstable preexist psychiatric , familial , geographic social condition could interfere medical followup compliance study procedures 5 . Subject law protect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>